BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29240299)

  • 21. Enzyme replacement therapy and/or hematopoietic stem cell transplantation at diagnosis in patients with mucopolysaccharidosis type I: results of a European consensus procedure.
    de Ru MH; Boelens JJ; Das AM; Jones SA; van der Lee JH; Mahlaoui N; Mengel E; Offringa M; O'Meara A; Parini R; Rovelli A; Sykora KW; Valayannopoulos V; Vellodi A; Wynn RF; Wijburg FA
    Orphanet J Rare Dis; 2011 Aug; 6():55. PubMed ID: 21831279
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical manifestations and treatment of mucopolysaccharidosis type I patients in Latin America as compared with the rest of the world.
    Muñoz-Rojas MV; Bay L; Sanchez L; van Kuijck M; Ospina S; Cabello JF; Martins AM
    J Inherit Metab Dis; 2011 Oct; 34(5):1029-37. PubMed ID: 21541721
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ocular findings after allogeneic hematopoietic stem cell transplantation.
    Tabbara KF; Al-Ghamdi A; Al-Mohareb F; Ayas M; Chaudhri N; Al-Sharif F; Al-Zahrani H; Mohammed SY; Nassar A; Aljurf M
    Ophthalmology; 2009 Sep; 116(9):1624-9. PubMed ID: 19729097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Unrelated CD3/CD19-depleted peripheral stem cell transplantation for Hurler syndrome.
    Schwinger W; Sovinz P; Benesch M; Lackner H; Seidel M; Strenger V; Sperl D; Raicht A; Brunner-Krainz M; Paschke E; Plecko B; Urban C
    Pediatr Hematol Oncol; 2014 Nov; 31(8):723-30. PubMed ID: 25116402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combined enzyme replacement and haematopoietic stem cell transplantation in Hurler syndrome.
    Bijarnia S; Shaw P; Vimpani A; Smith R; Pacey V; O'Grady H; Christodoulou J; Sillence D
    J Paediatr Child Health; 2009; 45(7-8):469-72. PubMed ID: 19712183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The craniocervical junction following successful haematopoietic stem cell transplantation for mucopolysaccharidosis type I H (Hurler syndrome).
    Miebach E; Church H; Cooper A; Mercer J; Tylee K; Wynn RF; Wraith JE
    J Inherit Metab Dis; 2011 Jun; 34(3):755-61. PubMed ID: 21416193
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Corneal hysteresis in mucopolysaccharidosis I and VI.
    Fahnehjelm KT; Chen E; Winiarski J
    Acta Ophthalmol; 2012 Aug; 90(5):445-8. PubMed ID: 21232085
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Mucopolysaccharidosis type I, Hurler-Scheie phenotype with ocular involvement. Clinical and ultrastructural study].
    Girard B; Hoang-Xuan T; D'Hermies F; Savoldelli M; Bennouna M; Poenaru L; Maroteaux P; Pouliquen Y
    J Fr Ophtalmol; 1994; 17(4):286-95. PubMed ID: 8089412
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enzyme replacement therapy prior to haematopoietic stem cell transplantation in Mucopolysaccharidosis Type I: 10 year combined experience of 2 centres.
    Ghosh A; Miller W; Orchard PJ; Jones SA; Mercer J; Church HJ; Tylee K; Lund T; Bigger BW; Tolar J; Wynn RF
    Mol Genet Metab; 2016 Mar; 117(3):373-7. PubMed ID: 26832957
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Incidence and prevalence of mucopolysaccharidosis type 1 in the Irish republic.
    Murphy AM; Lambert D; Treacy EP; O'Meara A; Lynch SA
    Arch Dis Child; 2009 Jan; 94(1):52-4. PubMed ID: 18463126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incomplete biomarker response in mucopolysaccharidosis type I after successful hematopoietic cell transplantation.
    Kuiper GA; van Hasselt PM; Boelens JJ; Wijburg FA; Langereis EJ
    Mol Genet Metab; 2017 Sep; 122(1-2):86-91. PubMed ID: 28684085
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Objective Quantification of Changes in Corneal Clouding Over Time in Patients With Mucopolysaccharidosis.
    Javed A; Aslam T; Jones SA; Ashworth J
    Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):954-958. PubMed ID: 28170539
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neuropsychological development in children with Hurler syndrome following hematopoietic stem cell transplantation.
    Peters C; Shapiro EG; Krivit W
    Pediatr Transplant; 1998 Nov; 2(4):250-3. PubMed ID: 10084724
    [No Abstract]   [Full Text] [Related]  

  • 34. Residual α-L-iduronidase activity in fibroblasts of mild to severe Mucopolysaccharidosis type I patients.
    Oussoren E; Keulemans J; van Diggelen OP; Oemardien LF; Timmermans RG; van der Ploeg AT; Ruijter GJ
    Mol Genet Metab; 2013 Aug; 109(4):377-81. PubMed ID: 23786846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early disease progression of Hurler syndrome.
    Kiely BT; Kohler JL; Coletti HY; Poe MD; Escolar ML
    Orphanet J Rare Dis; 2017 Feb; 12(1):32. PubMed ID: 28193245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term outcomes of adaptive functions for children with mucopolysaccharidosis I (Hurler syndrome) treated with hematopoietic stem cell transplantation.
    Bjoraker KJ; Delaney K; Peters C; Krivit W; Shapiro EG
    J Dev Behav Pediatr; 2006 Aug; 27(4):290-6. PubMed ID: 16906003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evidence of Treatment Benefits in Patients with Mucopolysaccharidosis Type I-Hurler in Long-term Follow-up Using a New Magnetic Resonance Imaging Scoring System.
    Pontesilli S; Baldoli C; Rosa PAD; Cattoni A; Bernardo ME; Meregalli P; Gasperini S; Motta S; Fumagalli F; Tucci F; Baciga F; Consiglieri G; Canonico F; De Lorenzo P; Chiapparini L; Gentner B; Aiuti A; Biondi A; Rovelli A; Parini R
    J Pediatr; 2022 Jan; 240():297-301.e5. PubMed ID: 34547335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Outcomes of Long-Term Treatment with Laronidase in Patients with Mucopolysaccharidosis Type I.
    Laraway S; Mercer J; Jameson E; Ashworth J; Hensman P; Jones SA
    J Pediatr; 2016 Nov; 178():219-226.e1. PubMed ID: 27788836
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Quantifying medical manifestations in Hurler syndrome with the infant physical symptom score: associations with long-term physical and adaptive outcomes.
    Ahmed A; Rudser K; King KE; Eisengart JB; Orchard PJ; Shapiro E; Whitley CB
    Mol Genet Metab; 2022 May; 136(1):22-27. PubMed ID: 35304037
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metabolic Syndrome and Cardiovascular Risk Factors after Hematopoietic Cell Transplantation in Severe Mucopolysaccharidosis Type I (Hurler Syndrome).
    Braunlin E; Steinberger J; DeFor T; Orchard P; Kelly AS
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1289-1293. PubMed ID: 29409846
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.